Page 725 - Clinical Small Animal Internal Medicine
P. 725

63  Feline Inflammatory Liver Disease  693

                 Vitamin supplementation is usually beneficial in ano-  Development of fibrosis is seen with progression of the
  VetBooks.ir  rectic cats. B vitamins become rapidly depleted and thia-  disease. While the use of colchicine to reduce fibrosis has
                                                                  previously been advocated in dogs, there are no studies
               mine deficiency can contribute to neurologic signs, while
               cobalamin deficiency can exacerbate anorexia. Vitamin E
               is an antioxidant that also has antiinflammatory proper-  to demonstrate benefit. Moreover, its use can be associ-
                                                                  ated with significant side‐effects. Current medical advice
               ties. Vitamin K supplementation may be required to cor-  suggests that it not be recommended, although silymarin
               rect coagulopathies (Table 63.2).                  and UDCA may have potential antifibrotic effects.
                 Symptomatic therapy can include antiemetics (e.g.,   Our poor understanding of the etiopathogenesis of the
               metoclopramide or maropitant) and gastroprotectants   cholangitis‐cholangiohepatitis complex, and lack of con-
               (e.g., H2 blockers, proton pump inhibitors, sucralfate).   trolled clinical trials, combined with an inability on occa-
               Control of vomiting is important for patient comfort and   sions to obtain diagnostic samples before antibacterial
               to reduce the risk of feeding tubes becoming dislodged.   therapy, can often result in initiation of therapy with an
               Gastroprotectants may be beneficial due to the presence   antibacterial along with other supportive therapies as
               of concurrent inflammatory bowel disease and to address   indicated. If a diagnosis of NC has been made, and
               gastritis induced by persistent vomiting (see Table 63.2).  improvement has plateaued, prednisolone at antiinflam-
                 S‐adenosyl‐L‐methionine (SAM‐e) has a number of   matory doses could be introduced as this may be benefi-
               hepatoprotectant  effects: it  is a glutathione precursor   cial in attenuating the inflammatory response.
               (hence  antioxidant properties), it  stabilizes cell  mem-
               branes, and it modulates inflammatory cytokines. As low
               glutathione levels are present in a high percentage of cats     Prognosis
               with hepatobiliary disease, administration of SAM‐e
               should be beneficial, although no published data exist to   Prognosis will depend on the severity of the disease.
               support this claim (see Table 63.2).               Obstruction of the bile duct, necessitating surgical inter-
                 Ursodeoxycholic acid (UDCA) is a hydrophilic bile   vention, has a guarded prognosis, particularly where bil-
               acid that has a number of benefits: choloresis, that is,   iary diversion surgery is required. Cats with ascites
               making  the  bile more liquid  and  promoting  bile  flow;   similarly have a guarded prognosis as this is likely to rep-
               replacement of more toxic, hydrophobic bile acids; antia-  resent the presence of significant fibrosis. However, cats
               poptosis; antioxidant; and immunomodulation (see   that survive the initial acute phase of NC or that are diag-
               Table 63.2). It has been used as the sole therapy for treat-  nosed with LC often go on to live for several years.
               ment of primary sclerosing cholangitis in people, but its   Relapses are possible, especially if there is a concurrent
               use as sole therapy for treatment of LC in cats did not   condition such as pancreatitis that may be difficult to
               compare favorably to prednisolone.                 control.
                 Immunosuppression is considered  important  for the   Lymphocytic cholangitis is likely a progressive disease,
               management of LC, but should only be commenced once   and dilation of the bile ducts may be irreversible. This has
               NC  has  been  ruled  out.  Prednisolone  is  typically   been proposed to increase the risk of these cats develop-
               employed, starting at higher, immunosuppressive doses   ing ascending infections and potentially cholecystitis,
               and tapering to as low a dose as possible once in remis-  therefore although recurrence is not inevitable, periodic
               sion (see Table 63.2). Some authors have also advocated   monitoring of liver parameters +/‐ ultrasonographic eval-
               the use of methotrexate or chlorambucil.           uation of the biliary system may be warranted.


                 Further Reading


               Callahan Clark JE, Haddad J, Brown D, et al. Feline   Twedt DC, Cullen J, McCord K, et al. Evaluation of
                 cholangitis: a necropsy study of 44 cats (1986–2008).   fluorescence in situ hybridization for the detection of
                 J Feline Med Surg 2011; 13(8): 570–6.              bacteria in feline inflammatory liver disease. J Feline
               Otte CM, Gutierrez O, Favier R, et al. Detection of   Med Surg 2014; 16(2): 109–17.
                 bacterial DNA in bile of cats with lymphocytic   Warren A, Center S, McDonough S, et al. Histopathologic
                 cholangitis. Vet Microbiol 2012; 156(1–2): 217–21.  features, immunophenotyping, clonality and eubacterial
               Otte CM, Penning L, Rothuizen J, Favier R. Retrospective   fluorescence in situ hybridisation in cats with
                 comparison of prednisolone and ursodeoxycholic     lymphocytic cholangitis/cholangiohepatitis. Vet Pathol
                 acid for the treatment of feline lymphocytic cholangitis.   2011; 48(3): 627–41.
                 Vet J 2013; 195(2): 205–9.
   720   721   722   723   724   725   726   727   728   729   730